Results 21 to 30 of about 66,503 (250)

A Case of Autoimmune Hemolytic Anemia after the First Dose of COVID-19 mRNA-1273 Vaccine with Undetected Pernicious Anemia

Case Reports in Hematology, 2022
By this time, multiple vaccines have been approved to limit the spread of SARS-CoV-2 worldwide. These include new-generation vaccines that contain mRNA of the target organism.
Fnu Jaydev, Vinodh Kumar, Jaikumar Khatri, S. Shahani, S. Beganovic   +4 more
semanticscholar   +1 more source

Infectious Complications in Autoimmune Hemolytic Anemia

Journal of Clinical Medicine, 2021
Autoimmune hemolytic anemia (AIHA) may be frequently challenged by infectious complications, mainly as a result of immunosuppressive treatments administered. Furthermore, infectious agents are known triggers of AIHA onset and relapse. Although being risk
J. Giannotta, B. Fattizzo, F. Cavallaro, W. Barcellini   +3 more
semanticscholar   +1 more source

Bortezomib in autoimmune hemolytic anemia and beyond

Therapeutic Advances in Hematology, 2021
Bortezomib is a first-in-class, potent, selective and reversible proteasome inhibitor approved for the treatment of multiple myeloma (MM) and relapsed/refractory mantle cell lymphoma.
R. Pasquale, J. Giannotta, W. Barcellini, B. Fattizzo   +3 more
semanticscholar   +1 more source

A case of severe autoimmune hemolytic anemia after a receipt of a first dose of SARS‐CoV‐2 vaccine

International Journal of Laboratory Hematology, 2021
SARS-CoV-2 mRNA vaccine made by Pfizer and BioNTech was approved by the U.S. Food and Drug Administration for use under an Emergency Use Authorization for active immunization to prevent coronavirus disease caused by severe acute respiratory syndrome ...
T. Murdych
semanticscholar   +1 more source

A Case of Autoimmune Hemolytic Anemia Following COVID-19 Messenger Ribonucleic Acid Vaccination

Cureus, 2021
Autoimmune hemolytic anemia (AIHA) is a condition characterized by the increased destruction of red blood cells (RBCs) mediated by anti-erythrocyte autoantibodies with or without complement activation.
Sérgio Brito, N. Ferreira, S. Mateus, M. Bernardo, Beatriz Pinto, A. Lourenço, F. Grenho   +6 more
semanticscholar   +1 more source

CAQ Corner: Immune‐mediated complications

, 2022
Liver Transplantation, EarlyView.
Mary Thomson, John R. Lake
wiley   +1 more source

Diagnosis and Management of Autoimmune Hemolytic Anemia in Patients with Liver and Bowel Disorders

Journal of Clinical Medicine, 2021
Anemia is a common feature of liver and bowel diseases. Although the main causes of anemia in these conditions are represented by gastrointestinal bleeding and iron deficiency, autoimmune hemolytic anemia should be considered in the differential ...
C. Bianco, E. Coluccio, D. Prati, Luca Valenti   +3 more
semanticscholar   +1 more source

Autoimmune Hemolytic Anemia and Pulmonary Embolism: An Association to Consider

TH Open, 2021
Autoimmune hemolytic anemia (AIHA) is increasingly recognized as a strong risk factor for venous thrombosis. However, there are currently no guidelines on thromboembolism prevention and management during AIHA. Here, we describe the case of a patient with
D. Solari, L. Alberio, C. Ribi, F. Grandoni, G. Stalder   +4 more
semanticscholar   +1 more source

Warm Autoimmune Hemolytic Anemia Associated With Asymptomatic SARS-CoV-2 Infection

Cureus, 2021
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the resultant coronavirus disease 2019 (COVID-19) are associated with several hematologic abnormalities, including immune thrombocytopenia, antiphospholipid syndrome, and autoimmune ...
Joseph R Liput, K. Jordan, R. Patadia, Elizabeth M Kander   +3 more
semanticscholar   +1 more source

Clinical relevance of silent red blood cell autoantibodies. [PDF]

, 2017
.
Alessandri, C, Caputo, Md, Colafigli, G, Coluzzi, S, De Propris, Ms, Foà, R, Giovannetti, G, Girelli, G, Guarini, Ar, Mauro, Fr, Pepe, S, Porrazzo, M, Riemma, C, Trastulli, F, Valesini, G   +14 more
core   +1 more source